Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
According to recent studies Subclinical hypothyroidism (SCH) may be independently associated with diabetic nephropathy in individuals with diabetes mellitus. Individuals with type 2 diabetes found no history of thyroid disease. Researchers evaluated the serum thyroid hormone levels and urinary albumin:creatinine ratio within the respective study. They characterized SCH as an elevated level of thyroid-stimulating hormone and diabetic nephropathy as Creatinine levels of 300 mg/g or even higher. The vogue of diabetic nephropathy was significantly higher in the SCH than the euthyroid group. On multivariate analysis, SCH was correlated with a 3.5 times increased bulge of diabetic nephropathy and a 4.6 times increased odds of hypertension, SCH was not exclusively associated with chronic kidney disease. These outcomes entail that SCH may be a new therapeutic target to prevent the advancement and progression of renal disease in diabetes individuals; thyroid function screening should be offered to diabetes patients with diabetic nephropathy.